Cargando…
The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles
Chronic kidney disease (CKD) affects 15% of the US adult population. However, most clinically available drugs for CKD show low bioavailability to the kidneys and non‐specific uptake by other organs which results in adverse side effects. Hence, a targeted, drug delivery strategy to enhance kidney dru...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510478/ https://www.ncbi.nlm.nih.gov/pubmed/33005739 http://dx.doi.org/10.1002/btm2.10173 |